CHICAGO -- For the first time in a multicenter randomized trial, minimally invasive glaucoma surgery (MIGS) with an intracanalicular (Schlemm's canal) stent significantly reduced long-term vision loss ...
The HORIZON trial, which compared cataract surgery alone with cataract surgery in conjunction with implantation of the Hydrus Microstent (Ivantis, Inc; Irvine, California), concluded at 3 years that ...
Please provide your email address to receive an email when new articles are posted on . ROME — Implantation of the Hydrus microstent in combination with cataract surgery or as a stand-alone procedure ...
Three years after Alcon pulled its CyPass Micro-Stent from the market due to safety concerns, the Novartis spinoff has found another glaucoma treatment device to take its place. The Hydrus Microstent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results